PTX3 and pulmonary fibrosis: Our results suggested that targeting PTX3 significantly recovered body weight loss, reduced the severity of pulmonary fibrosis, and decreased the extent of pulmonary damage in the therapeutic treatment model (Figures 2 and 5).